A Benchmark Study of Deep Learning Methods for Multi-Label Pediatric Electrocardiogram-Based Cardiovascular Disease Classification
This provides reusable baselines for pediatric ECG-based disease screening, though it is incremental as it benchmarks existing methods on new data.
This paper presents the first benchmark study of deep learning methods for multi-label pediatric cardiovascular disease classification using ECG data, achieving strong results including a macro-F1 score of 94.67% with ResNet-1D and Hamming Loss as low as 0.0069.
Cardiovascular disease (CVD) is a major pediatric health burden, and early screening is of critical importance. Electrocardiography (ECG), as a noninvasive and accessible tool, is well suited for this purpose. This paper presents the first benchmark study of deep learning for multi-label pediatric CVD classification on the recently released ZZU-pECG dataset, comprising 3716 recordings with 19 CVD categories. We systematically evaluate four representative paradigms--ResNet-1D, BiLSTM, Transformer, and Mamba 2--under both 9-lead and 12-lead configurations. All models achieved strong results, with Hamming Loss as low as 0.0069 and F1-scores above 85% in most settings. ResNet-1D reached a macro-F1 of 94.67% on the 12-lead subset, while BiLSTM and Transformer also showed competitive performance. Per-class analysis indicated challenges for rare conditions such as hypertrophic cardiomyopathy in the 9-lead subset, reflecting the effect of limited positive samples. This benchmark establishes reusable baselines and highlights complementary strengths across paradigms. It further points to the need for larger-scale, multi-center validation, age-stratified analysis, and broader disease coverage to support real-world pediatric ECG applications.